ClinicalTrials.gg

Torticollis clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 121 studies for Torticollis across more than 10 countries. 18 are recruiting or about to start. 99 of them are mainly about Torticollis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Status

Completed
84
Recruiting
12
Terminated
8
Status unknown
8
Not yet recruiting
3
Enrolling by invitation
3

Phase

Phase 2
19
Phase 3
13
Phase 4
12
Phase 1
8
Early Phase 1
1

Where

United States
57
Canada
16
France
14
Germany
12
United Kingdom
8
Austria
8

Who develops what

Add Torticollis to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 3 programs from 3 companies, 2 with this as their studies’ main aim; 0 with a live phase 3 study; 2 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 3 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (2)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • Mar 2027 est.VIM0423 · Vima Therapeutics · Phase 2 registry mapping onlyNCT07304089 A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia — primary endpoint: Change from baseline in Burke-Fahn-Marsden (BFM) Dystonia Rating Scale · 100 enrolled
  • 26 Mar 2027 est.corabotase · Ipsen · Phase 2 main aimNCT06937931 A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults — primary endpoint: Change from Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score · 132 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Torticollis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

0phase 3 studies under way
9studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9

Who these studies take

Of the 12 Torticollis studies recruiting now, 4 (33%) set no upper age limit and 4 (33%) stop at 75 or younger. 2 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (25%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
101 (8%)1 (8%)
1810 (83%)10 (83%)
3011 (92%)11 (92%)
4011 (92%)11 (92%)
5011 (92%)11 (92%)
6511 (92%)11 (92%)
7510 (83%)10 (83%)
857 (58%)7 (58%)

Across all 121 studies, recruiting or not: 36% stop at 75 or younger and 16% at 65; 24% take children; 0% are for women only and 1% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Torticollis studies take

Of 13 observational studies under Torticollis, half reached primary completion within 33 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational33 mo7–58 · 13 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 121. Browse all 121 → or search them.